For the first time, scientists have shown that an established blood cleansing process could help get rid of the human body of tiny plastic particles, providing hope for new detoxification solutions in the midst of increasing global infection.
​​​​​​​Study: Therapeutic removal: a very promising method for removing microplastics? Credit Picture: Siverstockstudio / Shutterstock
Increasing the use of plastics is associated with mass and extensive environmental contamination with plastics. Many evidence shows that in their degraded form they have entered living organisms, including the human body. A recent article in Brain Medicine magazine states the feasibility of removing such plastic forms using an established technique called therapeutic abstraction.
Import
Minds and nanoplasts are plastic forms with larger diameters of 1 µm -5 mm and <1 µm in a larger diameter, respectively. Together, they are called MNP.
MNPS may be by -products of commercial production cycles that include goods such as medicinal preparations or cosmetics. They can also represent a stage of downgrading plastic waste.
MNP exists everywhere in the world, including marine and forest environments. Recent research strongly implies their threat to human health and possibly links them to multiple health conditions. The scientific document notes that due to today’s methodological restrictions, it is often more expensive to talk about MNPs or MNP type structures, which may include MNPs in combination with other molecules such as proteins and that reports on the presence of MNP tissues should be interpreted with some care. These include cardiomotyometabolic disease (such as stroke, heart disease, type 2 diabetes and metabolic syndrome), cancer, infertility, dementia and other neurodegenerative conditions.
Such disorders can be activated or accelerated by the presence of MNPs. For example, some scientists assume that MNPs obtained from adrenal tissues may disrupt normal adrenal production such as cortisol. Cortisol, which is a hormone stress, abnormal levels of cortisol in the blood can formulate stress reactions. This can explain why many viral infections are currently followed by chronic fatigue after a clinical recovery. A further theory is that MNPs help to transport infectious agents to cells and tissues.
Currently, exposure to MNP is inevitable, leading researchers to investigate whether it can be effectively removed from the body.
Authors of the current study examined the use of therapeutic abstraction to remove MNPs from the body. Currently, this technique is used to remove certain blood components, such as cells or plasma proteins.
For the study
Myalgian encephalomyelitis/chronic fatigue syndrome (ME/CFS) has been dramatically more widespread in recent years. This is related to the increase in air pollution by 10mm particles or less in size.
In a previous study by the same authors, patients with ME/CFS reported a 70% improvement in symptoms after receiving this treatment. It is important to note that this previous observation is related to the improvement of symptoms and did not specifically investigate the removal of MNP. The current study took it further in search of the presence of MNP particles in the ecclesiastical liquid.
For therapeutic removal
Therapeutic removal is basically a filtration process. The blood from the patient passes through a vein via a circuit that includes an abstraction machine containing a series of filters designed to remove different blood ingredients. For example, one set of filters can remove autoantibodies, while another may target blood lipids.
Filtered blood is now transferred to the patient using a second vein. The eject will be enriched in the ingredients removed from the blood.
Study findings
In the current study, 21 patients with meta-in-law ME/CFS were treated using two circles of therapeutic abstraction or more, using double filtration. The concentrated ecclesa was measured by a sophisticated analytical method called impaired spectroscopy of overall transformation transformation reflection (ATR-FT-Ir). It is important to note that this analysis is not quantitatively measured by MNPs. It only determines whether there are MNP particles or not.
This revealed 14 types of substances or mixes that resemble MNP -type particles I was closed by these patients, but not the liquid prerinse. The IR spectrum showed a 67.5% match for polyamide 6 (Nylon 6) and 35.3% matching for polyurethane (PUR-WS). Some of these particles were 200 Nm in size or smaller.
This may be due to the presence of polyamide 6, a synthetic polymer produced mainly as fibers and not as a particle, which is manufactured as an electricity fiber <100 Nm for certain specialized applications.
This spectroscopic method determines the presence of polyamide bonds, although this may indicate the presence of proteins as well. This limits the definition of this observation on the exact synthesis of the traced particles.
Conclusions
This study first states a method that could potentially be used to remove MNP particles from the human body. More studies are required to validate this application.
In addition, plasma MNP levels pre- and after visualization must be quantitatively measured, along with ELUTE MNPS, in more than one cycle of removal. This will show how well these particles are removed from the blood and then from the tissues. The clinical effects of the removal of MNP from the body also need confirmation and it should be emphasized that such results have not yet been established by this preliminary research.
